| Dr Mehmet Bozkurt, MD | |
|
Cleveland Clinic 9500 Euclid Avenue A60, Cleveland, OH 44195-0001 | |
| (216) 445-4724 | |
| Not Available |
| Full Name | Dr Mehmet Bozkurt |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | Cleveland Clinic 9500 Euclid Avenue A60, Cleveland, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639455546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 208200000X (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mehmet Bozkurt, MD 27030 Cedar Rd Apt 721-2, Beachwood, OH 44122-1195 Ph: (440) 317-4242 | Dr Mehmet Bozkurt, MD Cleveland Clinic 9500 Euclid Avenue A60, Cleveland, OH 44195-0001 Ph: (216) 445-4724 |
News Archive
In a recent edition of VOA News' "Science In The News," correspondents Bob Doughty and Shirley Griffith report on "the growing use of generic drugs in fighting HIV" and discuss "the search for an effective vaccine against HIV."
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non-Responders (INR) after at least 24 months of highly active anti-retroviral therapy (HAART).
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care
Scientists are reporting discovery of a potential new drug for epidemic keratoconjunctivitis (EKC) - sometimes called "pink eye" - a highly infectious eye disease that may occur in 15 million to 20 million people annually in the United States alone. Their report describing an innovative new "molecular wipe" that sweeps up viruses responsible for EKC appears in ACS's Journal of Medicinal Chemistry.
› Verified 3 days ago
David Rowe, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Fatma Betul Tuncer, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-2200 Fax: 216-444-9419 | |
Isaac B James, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-445-4724 | |
Dr. Bahar Bassiri Gharb, M.D., PHD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, A60, Cleveland, OH 44195 Phone: 502-377-3424 | |
Dr. Kyle James Chepla, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-4450 | |
Daniel A. Medalie, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Randall J Yetman, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 |